DYAI logo

Dyadic International (DYAI) Company Overview

Profile

Full Name:

Dyadic International, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

January 16, 2008

Indexes:

Not included

Description:

DYAI (Dyadic International) is a biotechnology company that focuses on developing and producing proteins for various industries, including pharmaceuticals and agriculture. They use advanced technology to create efficient and cost-effective solutions, helping to improve health and sustainability worldwide.

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 14, 24 HC Wainwright & Co.
Buy
Jul 8, 24 HC Wainwright & Co.
Buy
Nov 13, 23 HC Wainwright & Co.
Buy
May 24, 23 HC Wainwright & Co.
Buy
Feb 3, 23 HC Wainwright & Co.
Buy
Jul 18, 22 Dawson James
Neutral
Apr 5, 22 HC Wainwright & Co.
Buy
Dec 17, 21 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Dyadic International?
  • Does Dyadic International pay dividends?
  • What sector is Dyadic International in?
  • What industry is Dyadic International in?
  • What country is Dyadic International based in?
  • When did Dyadic International go public?
  • Is Dyadic International in the S&P 500?
  • Is Dyadic International in the NASDAQ 100?
  • Is Dyadic International in the Dow Jones?
  • When was Dyadic International's last earnings report?
  • When does Dyadic International report earnings?
  • Should I buy Dyadic International stock now?

What is the ticker symbol for Dyadic International?

The ticker symbol for Dyadic International is NASDAQ:DYAI

Does Dyadic International pay dividends?

No, Dyadic International does not pay dividends

What sector is Dyadic International in?

Dyadic International is in the Healthcare sector

What industry is Dyadic International in?

Dyadic International is in the Biotechnology industry

What country is Dyadic International based in?

Dyadic International is headquartered in United States

When did Dyadic International go public?

Dyadic International's initial public offering (IPO) was on January 16, 2008

Is Dyadic International in the S&P 500?

No, Dyadic International is not included in the S&P 500 index

Is Dyadic International in the NASDAQ 100?

No, Dyadic International is not included in the NASDAQ 100 index

Is Dyadic International in the Dow Jones?

No, Dyadic International is not included in the Dow Jones index

When was Dyadic International's last earnings report?

Dyadic International's most recent earnings report was on Nov 12, 2024

When does Dyadic International report earnings?

The next expected earnings date for Dyadic International is Mar 28, 2025

Should I buy Dyadic International stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions